Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong · Delayed Price · Currency is HKD 0.9000
-0.0300 (-3.23%)
Jul 31, 2026, 4:08 PM HKT
HKG:0460 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,618 | 2,618 | 1,901 | 1,861 | 2,181 | 3,038 |
Revenue Growth | 24.81% | 37.71% | 2.18% | -14.70% | -28.21% | 23.30% |
Gross Profit Gross Profit Growth | 1,802 | 1,802 | 1,242 | 1,296 | 1,488 | 2,430 |
Operating Income Operating Income Growth | 476.72 | 476.72 | -389.41 | -140.54 | -536.05 | 676.2 |
Net Income Net Income Growth | 179.7 | 179.7 | -216.66 | -54.02 | -1,915 | 416.51 |
Earnings Per Share EPS Growth | 0.02 | 0.02 | -0.02 | -0.01 | -0.21 | 0.04 |
EPS Growth | - | - | - | - | - | -12.20% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Generic Medicine Generic Medicine Growth | 956.32 | 956.32 | 1,099 | 1,399 | 1,970 | 2,598 |
Innovative Medicine and Other Medicine Innovative Medicine and Other Medicine Growth | 232.42 | 232.42 | 109.67 | 36.77 | 165.71 | 105.11 |
Medical Aesthetic Products Medical Aesthetic Products Growth | 1,485 | 1,485 | 744.22 | 449.91 | 149.78 | 398.95 |
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth | -56 | -56 | -52.08 | -24.99 | -104.8 | -63.81 |
Total Total Growth | 2,618 | 2,618 | 1,901 | 1,861 | 2,181 | 3,038 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,977 | 3,977 | 3,777 | 4,498 | 4,792 | 5,792 |
Total Debt Total Debt Growth | 971.69 | 971.69 | 942.77 | 1,251 | 1,291 | 1,081 |
Net Cash (Debt) Net Cash Growth | 3,006 | 3,006 | 2,834 | 3,246 | 3,501 | 4,710 |
Net Cash Growth | 16.87% | 6.05% | -12.70% | -7.27% | -25.67% | 12.64% |
Net Cash Per Share Net Cash Per Share Growth | 0.33 | 0.33 | 0.31 | 0.35 | 0.38 | 0.50 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -23.56 | -23.56 | 276.14 | 199.49 | 46.49 | 665.29 |
Capital Expenditures CapEx Growth | -58.35 | -58.35 | -70.71 | -125.35 | -402.46 | -601.02 |
Free Cash Flow Free Cash Flow Growth | -81.91 | -81.91 | 205.44 | 74.14 | -355.97 | 64.28 |
Free Cash Flow Growth | - | - | 177.09% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.83% | 68.83% | 65.31% | 69.64% | 68.20% | 79.99% |
Operating Margin | 18.21% | 18.21% | -20.48% | -7.55% | -24.58% | 22.25% |
Pretax Margin | 15.93% | 15.93% | -22.53% | -8.67% | -97.32% | 16.32% |
Profit Margin | 6.86% | 6.86% | -11.40% | -2.90% | -87.79% | 13.71% |
FCF Margin | -3.13% | -3.13% | 10.81% | 3.98% | -16.32% | 2.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.022 | 0.019 | 0.019 | - | 0.033 | 0.013 |
Dividend Per Share Growth | 0% | 2.63% | - | - | 153.85% | -7.14% |
Dividend Yield | 2.48% | 1.79% | 3.12% | - | 4.37% | 1.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 41.06 | 55.85 | - | - | - | 27.01 |
Forward PE | 9.69 | 27.63 | 48.21 | 118.00 | 38.55 | 8.90 |
P/FCF Ratio | - | - | 27.96 | 74.25 | - | 175.02 |
PS Ratio | 2.79 | 3.83 | 3.02 | 2.96 | 3.60 | 3.70 |